a place in ophthalmology which can be described as both -ethical and valuable.
With this in mind it is desirable that comprehensive contributions to the relevant literature should be seen to build on this late foundation and not to turn the clock -either back or too far forwards with ill-advised haste. In this respect, this book falls short of what is required. It represents a very personal account of Dr Scharchar's views, with much detail about his surgical techniques and the value of his design of implant. His views are unsupported by statistical evidence of his own, and no mention is made of the need to make further study and -assessment of results and complications in a proper scientific manner.
Because of the number of astonishing and possibly dangerous assertions such as that ac-chymotrypsin causes glaucoma and delayed wound rupture. or that endothelial dystrophy does not constitute a contraindication to implant surgery, this book should be regarded as unsuitable for postgraduate study, unless read with well-,developed critical faculties. The text is not assisted by medical illustrations of poor quality.
This book reflects an attitude in favour of implantation -for almost every type of patient with cataract and belittles the disadvantages, attributing most complica--tions to faulty surgical technique rather than to unsatis- The editorial4 appears to make the mistake of equating *CRVO with BRVO. The articles describe studies of BRVO and not CRVO, and the author of the editorial has drawn conclusions from those studies on the BRVO only. CRVO and BRVO are 2 very distinct conditions. The anatomy of the CRV, the various physiological and pathological aspects of its blood flow, and the pathogenetic factors in its occlusion are very different from those of the BRV. Moreover, studies reported do not -even reproduce all aspects of the clinical syndrome of BRVO in the animals. To apply the findings to CRVO (without doing any exhaustive studies on CRVO) is in my view ridiculous.
In the field of research, the emergence of new facts and evidence makes us modify our views as we go along, provided we keep an open scientific mind. My studies, conducted in the early 1960s and published in 1965,5 were conducted on a small series and, more importantly, before the advent of fluorescein angiography and it was impossible to determine the extent and type of occlusion of retinal vessels under those experimental conditions. Our recent studies6 clearly revealed the limitations in those earlier studies, and the consequent erroneous impressions. Recently we pointed out6 the discrepancy in the 1965 study in the light of our recent findings, but the author of the editorial has taken no notice of that fact. The editorial writer even misrepresents our current views on the subject.
According to the author of the editorial, 'the difference in the clinical appearances [between the CRVO and BRVO] are due to differences in the site of the obstruction'. Site of occlusion undoubtedly plays an important role in the severity of the clinical picture of CRVO, and we strongly emphasised this fact in our paper,6 but that does not explain everything about the pathogenesis of CRVO. For example, one-third of the patients with CRVO have ocular hypertension or chronic simple glaucoma, whereas in BRVO the incidence is no higher than in the general population.
The author admits the presence of 'ischaemic capillaropathy '. Group's opinion that: (1) The clinical picture of both CRV occlusion and BRV occlusion is produced by outflow obstruction and the differences in appearance are due to the differences in siting of the occlusion. Chronic simple glaucoma in CRVO does not alter my views; it is just one factor which contributes to or precipitates venous stasisprobably when flow is at its lowest, intravascular pressure is at its lowest and intraocular pressure at its highest.
(2) The disagreement between us, which is now very narrow, is on the production or pathogenesis of ischaemic capillaropathy. We suggest that the primary lesion is in the vein and that raised intravascular pressure, 
European Ophthalmic Pathology Society
The European Ophthalmic Pathology Society held its annual meeting in Brussels on 14-17 May 1979. Dr Hugh Greer, of Melbourne, Australia, was the guest of honour. The scientific programme included 39 case presentations by members and guests, and 17 countries were represented. For each presentation a protocol, histopathological sections, and appropriate clinical or macroscopic transparencies were provided.
The majority of case presentations dealt with inflammatory and metabolic disorders involving the globe, orbit, or eyelid, and the discussion was concerned predominantly with the nature of the biochemical disturbance. Malignant disease was also a prominent subject of the presentations, and the remainder of the cases provided examples of congenital malformation of the ocular tissues.
